Tochigi, Japan

Fumiko Kanou

This inventor holds 1 USPTO granted patent. Top assignee: Snow Brand Milk Products Co., Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumiko Kanou. Retrieved from https://idiyas.com/inventor/fumiko-kanou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumiko Kanou: Innovator in Peptide Inhibition

Introduction

Fumiko Kanou is a distinguished inventor based in Tochigi, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of peptide inhibitors. Her work has implications for various therapeutic applications, showcasing her innovative spirit and dedication to scientific advancement.

Latest Patents

Fumiko Kanou holds a patent for "Prolyl endopeptidase inhibitors SNA-115 and SNA-115T, and process for." This patent represents her pioneering efforts in creating compounds that can potentially lead to new treatments for diseases related to peptide metabolism. The patent highlights her expertise and commitment to advancing medical science.

Career Highlights

Throughout her career, Fumiko has been associated with Snow Brand Milk Products Co., Ltd., where she has been able to apply her knowledge and skills in a practical setting. Her role at the company has allowed her to contribute to innovative projects that bridge the gap between research and real-world applications.

Collaborations

Fumiko Kanou has collaborated with notable colleagues, including Kenichi Kimura and Hidetoshi Takahashi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research.

Conclusion

Fumiko Kanou's contributions to the field of peptide inhibition exemplify her innovative mindset and dedication to scientific progress. Her patent and collaborations reflect her commitment to advancing biochemistry and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…